People

Our Team

AI Therapeutics boasts a highly accomplished team with executional expertise across all stages of clinical development.

Leadership
Brigette Roberts, M.D.
CEO
Paul Boni
COO
Peter Young, Ph.D.
Chief Scientific Officer
Scott B Kozak
Chief Business Development Officer
Keith Fandrick, Ph.D.
Chief Development Officer
Joan Edwards
Chief Quality Assurance Officer
Esther Nkrumah, Ph.D.
Head of Clinical Operations
Brad Parry, Ph.D.
Head of AI
Board of Directors
Jonathan Rothberg, Ph.D.
George Rehm
Management
No items found.
Scientific Advisory Board
Lawrence Melvin, Ph.D.
Murat Gunel, M.D.
Chair
Tian Xu, Ph.D.